SCHEMBL29643283

SCHEMBL29643283

NC(=O)c1ccc2[nH]c3c(c2c1)CCCC3

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.74
MAPT P10636 8/20 0.72
SMN1; SMN2 Q16637 5/20 0.72
KDM4E B2RXH2 4/20 0.72
LMNA P02545 3/20 0.72
ALDH1A1 P00352 3/20 0.72
HTR1B P28222 3/20 0.65
MEN1 O00255 4/20 0.64
KMT2A Q03164 4/20 0.64
NPC1 O15118 1/20 0.64
RAB9A P51151 1/20 0.64
TP53 P04637 2/20 0.62
CASP1 P29466 1/20 0.62
HTR1A P08908 2/20 0.60
HTR1D P28221 1/20 0.60
POLB P06746 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
GFER P55789 1/20 0.54
MAPK1 P28482 1/20 0.53
MAPKAPK2 P49137 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6447738 1.00 F2 (0.74) F2MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL30571064 0.88 MAPT (0.62) F2MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL1586929 0.86 MAPT (0.70) F2MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL29643236 0.86 MAPT (0.70) F2MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL4258762 0.85 MAPT (0.68) F2MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL10738593 0.85 MAPT (0.68) F2MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL6243452 0.84 MAPT (1.00) F2MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL4283723 0.83 MAPT (0.66) F2MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL30523171 0.81 MEN1 (0.74) F2MAPTSMN1; SMN2KDM4ELMNA
SCHEMBL15281775 0.81 HTR1B (0.61) F2MAPTSMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230272401-A1 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF Genetic Intelligence, Inc 2023-08-31 US disclosed
CN-109206360-B Carbazole amide derivative or salt thereof, and preparation method and application thereof 复旦大学 2022-05-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230272401-A1 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF TARDBP, FUS, RBM17 F2 4778/4885MAPT 343/4885SMN1; SMN2 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.